In this podcast our team cover the evolution of pharmacy qualifications, looking at topics such as how are pharmacy undergraduate degrees changing? How often should curricula be reviewed? Can pharmacy degrees be broadened? or should pharmacy undergraduates be able to choose a specialisation early in their course?

Our team of experts: academics and pharmacists discuss the state of play around the changing nature of a pharmacy degree   

In this episode, speakers including Sam Kaitanpaa, Jacinta Johnson, Karalyn Huxhagen and Cathie Reid discuss the evidence for and against the use of medicinal cannabis by patients, the TGA’s approach to approval, and how pharmacists can discuss the topic both professionally and with patients.

For previous AJP podcasts, click here

Presented by AJP, Jarrod McMaugh and Carlene McMaugh (pictured above)

We look at areas such as prioritising workload, balancing patient expectations, problem solving and effective and safe multi-tasking.

Host Carlene McMaugh speaks to former PSA national President Shane Jackson, Sam Flood, Sam Kaitanpaa, Michael Troy and others for their tips on improving and enhancing your everyday experience of working in pharmacy.

We look at areas such as prioritising workload, balancing patient expectations, problem solving and effective and safe multi-tasking.

Host Carlene McMaugh speaks to former PSA national President Shane Jackson, Sam Flood, Sam Kaitanpaa, Michael Troy and others for their tips on improving and enhancing your everyday experience of working in pharmacy.

Has the Guild lost ground with the Coalition behind the scenes – and why was it so publicly supportive of one party over the other in the weekend’s election? In this episode, Carlene McMaugh discusses the 60-day script policy, why it would have been a disservice to pharmacists and patients, and why pharmacists need to speak up about what they do

Could double script lengths see pharmacists working for minimum wage and missing opportunities to spot treatment failure?

And what else might the Coalition implement unilaterally?

Note: The next podcast will be available on 6 June, which will cover the topic ‘Tips for a smoother work day’.

Has the Guild lost ground with the Coalition behind the scenes – and why was it so publicly supportive of one party over the other in the weekend’s election? In this episode, Carlene McMaugh discusses the 60-day script policy, why it would have been a disservice to pharmacists and patients, and why pharmacists need to speak up about what they do

Could double script lengths see pharmacists working for minimum wage and missing opportunities to spot treatment failure?

And what else might the Coalition implement unilaterally?

Note: The next podcast will be available on 6 June, which will cover the topic ‘Tips for a smoother work day’.

In this episode, Carlene McMaugh gains advice from leading pharmacists on some tips for starting your career, changing your career path or considering career options.

Among those Carlene speaks to are Karalyn Huxhagen, Cathie Reid, Kay Dunkley, Dr Mark Naunton and International Pharmaceutical Federation president Catherine Duggan, as we get a picture of the wide range of career options available to pharmacists, and some tips on how best to approach your career and to assess these options. 

In this episode, Carlene McMaugh gains advice from leading pharmacists on some tips for starting your career, changing your career path or considering career options.

Among those Carlene speaks to are Karalyn Huxhagen, Cathie Reid, Kay Dunkley, Dr Mark Naunton and International Pharmaceutical Federation president Catherine Duggan, as we get a picture of the wide range of career options available to pharmacists, and some tips on how best to approach your career and to assess these options. 

We speak to a wide range of pharmacists – from academics, to Guild leaders, to employed community pharmacists and hospital pharmacists – about the push to prescribe.

We cover topics like the potential conflict of interest, what might a prescribing model look like, should we instead focus on limited dose changes or better handling of S3 medicines, and many more